{"id":2680,"date":"2022-11-30T16:40:00","date_gmt":"2022-11-30T16:40:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/"},"modified":"2022-11-30T16:40:00","modified_gmt":"2022-11-30T16:40:00","slug":"christoffer-rosenblad-utsedd-till-vd-i-xvivo","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/","title":{"rendered":"Christoffer Rosenblad utsedd till VD i XVIVO"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Styrelsen i XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har utsett Christoffer Rosenblad till VD. Christoffer har varit tillf\u00f6rordnad VD sedan 27 september, 2022 och han tilltr\u00e4der nu rollen som VD med omedelbar verkan.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Styrelsen har efter att arbetet med att ta fram en tydlig kravprofil funnit att Christoffer Rosenblad fyller de krav som efterfr\u00e5gats. Det \u00e4r styrelsens bed\u00f6mning att Christoffer \u00e4r den mest l\u00e4mpade kandidaten att leda XVIVO i n\u00e4sta fas. De senaste 10 \u00e5ren har Christoffer haft en rad ledande befattningar i bolaget, s\u00e5som tillf\u00f6rordnad VD, COO, CFO och CEO f\u00f6r XVIVO Nordamerika. Christoffer har dessutom varit ansvarig f\u00f6r aff\u00e4rsutveckling och framg\u00e5ngsrikt lett de senaste \u00e5rens f\u00f6rv\u00e4rvsprocesser.<br \/>\u00a0<br \/>\u201dDet \u00e4r gl\u00e4djande att Christoffer tackat ja till uppdraget. Han k\u00e4nner s\u00e5v\u00e4l bolaget, transplantationsmarknaden samt kapitalmarknaden mycket v\u00e4l. Vi har en v\u00e4ldigt tydlig plan f\u00f6r vad vi vill \u00e5stadkomma de n\u00e4rmaste \u00e5ren och d\u00e4rf\u00f6r \u00e4r det ocks\u00e5 viktigt med kontinuitet\u201d s\u00e4ger G\u00f6sta Johannesson, ordf\u00f6rande i XVIVO.<\/p>\n<p>\u201dJag ser fram emot att f\u00e5 leda XVIVO in i framtiden, ett bolag vars vision \u201dIngen ska beh\u00f6va d\u00f6 i v\u00e4ntan p\u00e5 ett organ\u201d jag delar fullt ut. Med v\u00e5r unika produktportf\u00f6lj och med v\u00e5r starka organisation i ryggen st\u00e5r vi v\u00e4l rustade att leverera p\u00e5 v\u00e5r strategi\u201d s\u00e4ger Christoffer Rosenblad.<br \/>\u00a0<br \/>30 november, 2022<br \/>G\u00f6teborg<br \/>G\u00f6sta Johannesson, styrelseordf\u00f6rande<br \/>XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-1b9c6fa03ea2\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n<hr\/>\n<p>G\u00f6sta Johannesson, Styrelsens ordf\u00f6rande, tel: +46 8-614 00 30, e-post: <a target=\"_blank\" href=\"mailto:gosta.johannesson@bure.se\" rel=\"nofollow noopener\">gosta.johannesson@bure.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-da5f5ee9f867\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><\/p>\n<hr\/>\n<p>XVIVO grundades 1998 och \u00e4r ett medicintekniskt f\u00f6retag dedikerat till att f\u00f6rl\u00e4nga livet f\u00f6r donerade organ s\u00e5 att transplantationsteam runt om i v\u00e4rlden kan r\u00e4dda fler liv. V\u00e5ra l\u00f6sningar g\u00f6r det m\u00f6jligt f\u00f6r ledande kliniker och forskare att t\u00e4nja p\u00e5 gr\u00e4nserna f\u00f6r transplantationsmedicin.\u00a0XVIVO har sitt huvudkontor i G\u00f6teborg och har kontor och forskningsanl\u00e4ggningar p\u00e5 tv\u00e5 kontinenter. Bolaget \u00e4r noterat p\u00e5 Nasdaq Stockholm\u00a0och handlas under symbolen XVIVO. Mer information finns att l\u00e4sa p\u00e5 hemsidan www.xvivogroup.com\/us<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-mar\">\n<p><em>Denna information \u00e4r s\u00e5dan information som XVIVO Perfusion AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 2022-11-30 17:40 CET.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/c5d20e99-d68e-40a0-9f8d-c50e1d3419cc\/christoffer-rosenblad-utsedd-till-vd-i-xvivo.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Christoffer Rosenblad utsedd till VD i XVIVO<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Styrelsen i XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har utsett Christoffer Rosenblad till VD. Christoffer har varit tillf\u00f6rordnad VD sedan 27&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2680","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-staff"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Christoffer Rosenblad utsedd till VD i XVIVO - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Christoffer Rosenblad utsedd till VD i XVIVO - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Styrelsen i XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har utsett Christoffer Rosenblad till VD. Christoffer har varit tillf\u00f6rordnad VD sedan 27...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\\\/\",\"name\":\"Christoffer Rosenblad utsedd till VD i XVIVO - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-11-30T16:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Christoffer Rosenblad utsedd till VD i XVIVO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Christoffer Rosenblad utsedd till VD i XVIVO - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/","og_locale":"en_US","og_type":"article","og_title":"Christoffer Rosenblad utsedd till VD i XVIVO - XVIVO","og_description":"Styrelsen i XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har utsett Christoffer Rosenblad till VD. Christoffer har varit tillf\u00f6rordnad VD sedan 27...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/","name":"Christoffer Rosenblad utsedd till VD i XVIVO - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-11-30T16:40:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/christoffer-rosenblad-utsedd-till-vd-i-xvivo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Christoffer Rosenblad utsedd till VD i XVIVO"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}